MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: A nested case-control study

Breast Cancer Research

Volumn 11, Issue 6, 2009, Pages

  Maruti, Sonia S ^a,b,c   Ulrich, Cornelia M ^a,b   Jupe, Eldon R ^d   White, Emily ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

^d InterGenetics Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALCOHOL; CYANOCOBALAMIN; FOLIC ACID; METHIONINE; PYRIDOXINE; RIBOFLAVIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); VITAMIN B COMPLEX;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CARBON METABOLISM; CASE CONTROL STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA POLYMORPHISM; FEMALE; FOOD INTAKE; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; QUESTIONNAIRE; BREAST TUMOR; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHIONINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RISK FACTORS; VITAMIN B COMPLEX;

EID: 77954592857     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2462     Document Type: Article

References (49)

1. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 1995, 10:111-113. 10.1038/ng0595-111, 7647779.
2. Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, Curtis Ellison R, Eckfeldt JH, Rozen R. The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001, 156:409-415. 10.1016/S0021-9150(00)00671-7, 11395038.
3. Zintzaras E. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clinical Genetics 2006, 69:327-336. 10.1111/j.1399-0004.2006.00605.x, 16630166.
4. Macis D, Maisonneuve P, Johansson H, Bonanni B, Botteri E, Iodice S, Santillo B, Penco S, Gucciardo G, D'Aiuto G, Rosselli Del Turco M, Amadori M, Costa A, Decensi A. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res Treat. 2007, 106:263-271. 10.1007/s10549-006-9491-6, 17260091.
5. Lewis SJ, Harbord RM, Harris R, Smith GD. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. Journal of the National Cancer Institute 2006, 98:1607-1622.
6. Maruti SS, Ulrich CM, White E. Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. The American Journal of Clinical Nutrition 2009, 89:624-633. 10.3945/ajcn.2008.26568, 19116331.
7. White E, Patterson RE, Kristal AR, Thornquist M, King I, Shattuck AL, Evans I, Satia-Abouta J, Littman AJ, Potter JD. VITamins And Lifestyle cohort study: study design and characteristics of supplement users. American Journal of Epidemiology 2004, 159:83-93. 10.1093/aje/kwh010, 14693663.
8. Diergaarde B, Potter JD, Jupe ER, Manjeshwar S, Shimasaki CD, Pugh TW, Defreese DC, Gramling BA, Evans I, White E. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2008, 17:1751-1759. 2732341, 18628428, 10.1158/1055-9965.EPI-08-0168.
9. Patterson RE, Neuhouser ML, White E, Kristal AR, Potter JD. Measurement error from assessing use of vitamin supplements at one point in time. Epidemiology (Cambridge, Mass) 1998, 9:567-569.
10. Kristal AR, Feng Z, Coates RJ, Oberman A, George V. Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women's Health Trial Feasibility Study in Minority Populations. American Journal of Epidemiology 1997, 146:856-869.
11. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology 1999, 9:178-187. 10.1016/S1047-2797(98)00055-6, 10192650.
12. Satia-Abouta J, Patterson RE, King IB, Stratton KL, Shattuck AL, Kristal AR, Potter JD, Thornquist MD, White E. Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. American Journal of Epidemiology 2003, 157:944-954. 10.1093/aje/kwg039, 12746248.
13. Schakel SF, Buzzard IM, Gebhardt SE. Procedures for estimating nutrient values for food composition databases. J Food Composition Anal 1997, 10:102-114.
14. Dietary reference Intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. 2000, 210. Washington DC: Institute of Medicine, National Academy of Sciences.
15. Smith-Warner SA, Spiegelman D, Yaun SS, Brandt PA, Folsom AR, Goldbohm RA, Graham S, Holmberg L, Howe GR, Marshall JR, Miller AB, Potter JD, Speizer FE, Willett WC, Wolk A, Hunter DJ. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 1998, 279:535-540. 10.1001/jama.279.7.535, 9480365.
16. Campbell IG, Baxter SW, Eccles DM, Choong DY. Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res 2002, 4:R14. 137931, 12473175, 10.1186/bcr457.
17. Semenza JC, Delfino RJ, Ziogas A, Anton-Culver H. Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Res Treat. 2003, 77:217-223. 10.1023/A:1021843019755, 12602921.
18. Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, Yamashita T, Iwata H, Tajima K. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 2008, 29:356-362. 10.1093/carcin/bgm295, 18174236.
19. Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, Olsson H, Wirfalt E. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmo Diet and Cancer cohort. Cancer Epidemiol Biomarkers Prev 2009, 18:1101-1110. 10.1158/1055-9965.EPI-08-0401, 19336565.
20. Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS, Thun MJ, Calle EE. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev 2007, 16:1140-1147. 10.1158/1055-9965.EPI-06-1037, 17548676.
21. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hebert JR, Jin F, Zheng W. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2004, 13:190-196. 10.1158/1055-9965.EPI-03-0273, 14973091.
22. Ma E, Iwasaki M, Junko I, Hamada GS, Nishimoto IN, Carvalho SM, Motola J, Laginha FM, Tsugane S. Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC Cancer 2009, 9:122. 2684745, 19389261, 10.1186/1471-2407-9-122.
23. Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Santella RM. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Research 2005, 65:1606-1614. 10.1158/0008-5472.CAN-04-2630, 15735051.
24. Beilby J, Ingram D, Hahnel R, Rossi E. Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene. Eur J Cancer 2004, 40:1250-1254. 10.1016/j.ejca.2004.01.026, 15110890.
25. Sharp L, Little J, Schofield AC, Pavlidou E, Cotton SC, Miedzybrodzka Z, Baird JO, Haites NE, Heys SD, Grubb DA. Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Letters 2002, 181:65-71. 10.1016/S0304-3835(02)00030-7, 12430180.
26. Kotsopoulos J, Zhang WW, Zhang S, McCready D, Trudeau M, Zhang P, Sun P, Narod SA. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat. 2008, 112:585-593. 10.1007/s10549-008-9895-6, 18204969.
27. Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Henderson BE. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2004, 13:2071-2077.
28. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Weitzer W, Samonigg H. The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res Treat. 2003, 81:169-172. 10.1023/A:1025752420309, 14572159.
29. Justenhoven C, Hamann U, Pierl CB, Rabstein S, Pesch B, Harth V, Baisch C, Vollmert C, Illig T, Bruning T, Ko Y, Brauch H. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol Biomarkers Prev 2005, 14:3015-3018. 10.1158/1055-9965.EPI-05-0592, 16365030.
30. Ergul E, Sazci A, Utkan Z, Canturk NZ. Polymorphisms in the MTHFR gene are associated with breast cancer. Tumour Biol 2003, 24:286-290. 10.1159/000076460, 15004488.
31. Lee SA, Kang D, Nishio H, Lee MJ, Kim DH, Han W, Yoo KY, Ahn SH, Choe KJ, Hirvonen A, Noh DY. Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Experimental & Molecular Medicine 2004, 36:116-121.
32. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Res Treat. 2007, 104:299-308. 10.1007/s10549-006-9417-3, 17063264.
33. Hekim N, Ergen A, Yaylim I, Yilmaz H, Zeybek U, Ozturk O, Isbir T. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer. Cell Biochem and Funct. 2007, 25:115-117. 10.1002/cbf.1274.
34. Kalemi TG, Lambropoulos AF, Gueorguiev M, Chrisafi S, Papazisis KT, Kotsis A. The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Letters 2005, 222:57-65. 10.1016/j.canlet.2004.11.025, 15837541.
35. Chou YC, Wu MH, Yu JC, Lee MS, Yang T, Shih HL, Wu TY, Sun CA. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan. Carcinogenesis 2006, 27:2295-2300. 10.1093/carcin/bgl108, 16777985.
36. Langsenlehner T, Renner W, Yazdani-Biuki B, Langsenlehner U. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res Treat. 2007, 107:459-460. 10.1007/s10549-007-9564-1, 17453338.
37. Reljic A, Simundic AM, Topic E, Nikolac N, Justinic D, Stefanovic M. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study. Clinical Biochemistry 2007, 40:981-985. 10.1016/j.clinbiochem.2007.05.005, 17573062.
38. Inoue M, Robien K, Wang R, Berg DJ, Koh WP, Yu MC. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis 2008, 29:1967-1972. 2574755, 18669903, 10.1093/carcin/bgn177.
39. Yu CP, Wu MH, Chou YC, Yang T, You SL, Chen CJ, Sun CA. Breast cancer risk associated with multigenotypic polymorphisms in folate-metabolizing genes: a nested case-control study in Taiwan. Anticancer Research 2007, 27:1727-1732.
40. Cheng CW, Yu JC, Huang CS, Shieh JC, Fu YP, Wang HW, Wu PE, Shen CY. Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res Treat. 2008, 111:145-155. 10.1007/s10549-007-9754-x, 17896178.
41. Kundu TK, Rao MR. CpG islands in chromatin organization and gene expression. Journal of Biochemistry 1999, 125:217-222.
42. Lengauer C, Kinzler KW, Vogelstein B. DNA methylation and genetic instability in colorectal cancer cells. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:2545-2550. 20125, 9122232, 10.1073/pnas.94.6.2545.
43. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nature Reviews 2002, 3:415-428.
44. Bariol C, Suter C, Cheong K, Ku SL, Meagher A, Hawkins N, Ward R. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. The American Journal of Pathology 2003, 162:1361-1371. 1851239, 12651628.
45. Ulrich CM. Nutrigenetics in cancer research--folate metabolism and colorectal cancer. The Journal of Nutrition 2005, 135:2698-2702.
46. Ulrich CM, Kampman E, Bigler J, Schwartz SM, Chen C, Bostick R, Fosdick L, Beresford SA, Yasui Y, Potter JD. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction?. Cancer Epidemiol Biomarkers Prev 1999, 8:659-668.
47. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Olivieri O, Jacques PF, Rosenberg IH, Corrocher R, Selhub J. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:5606-5611. 122817, 11929966, 10.1073/pnas.062066299.
48. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996, 93:7-9.
49. Ulvik A, Ueland PM, Fredriksen A, Meyer K, Vollset SE, Hoff G, Schneede J. Functional inference of the methylenetetrahydrofolate reductase 677C > T and 1298A > C polymorphisms from a large-scale epidemiological study. Human Genetics 2007, 121:57-64. 10.1007/s00439-006-0290-2, 17115185.